Star Projects of MEXC’s 0 Trading Fee Fest (Nov 27, 2025)!🏆 Top 3 Gainers:🏅 $VELO | @veloprotocol🥈 $KAS | @kaspaunchained🥉 $VIRTUAL | @virtuals_ioNo trading fees, just pure gains! ...

🚀 Zero fees, real-world impact.Now you can trade $VELO on MEXC at 0 cost. @veloprotocol👇Start your 0-fee run today. ...

Financial Data and Key Metrics Changes - IDEXX reported a revenue increase of 13% as reported and 12% organically, with CAG Diagnostics' recurring revenues growing over 10% organically [4][5] - Earnings per share (EPS) for Q3 was $3.40, reflecting a 15% growth on a comparable basis [5][12] - The company increased its full-year revenue outlook to a range of $4,270 million to $4,300 million, representing an overall reported revenue growth of 9.6% to 10.3% [5][14] Business Line Data and Key Metrics Changes - CAG Diagnostics' recurring revenue growth was negatively impacted by a 1.2% decline in U.S. same-store clinical visits [4][6] - IDEXX VetLab Consumables revenues increased 16% organically, supported by the expansion of the premium instrument install base [9] - Global Rapid Assay revenues declined 5% organically due to a shift in testing to the Catalyst platform [10] Market Data and Key Metrics Changes - U.S. organic CAG Diagnostics' recurring revenues grew 8% in Q3, while international CAG Diagnostics' recurring revenue grew 14% organically [6][8] - Water revenues increased 7% organically, with strong growth in international regions [11] - Livestock, poultry, and dairy revenues increased 14% organically, with double-digit gains across most regions [11] Company Strategy and Development Direction - IDEXX aims to expand its CancerDx franchise in 2026, adding mass cell tumor detection and another high-impact cancer biomarker [19][29] - The company is focused on enhancing its commercial footprint in international markets, with plans to expand in three countries by early 2026 [22] - IDEXX's strategy includes continuous investment in innovation and commercial capabilities to drive growth and improve customer engagement [20][42] Management's Comments on Operating Environment and Future Outlook - Management noted that diagnostics remains the fastest-growing revenue stream within veterinary clinics, driven by increased testing frequency and utilization [18] - The company expects to see continued growth in clinical visits as the pet population ages, particularly among dogs and cats [51] - Management highlighted the importance of maintaining high customer retention levels and the ongoing demand for IDEXX's innovative solutions [20] Other Important Information - Free cash flow for Q3 was $371 million, with a net income to free cash flow conversion rate of 94% [12] - The company allocated $242 million for share repurchases during Q3, contributing to a 2.7% year-over-year reduction in diluted shares outstanding [14] Q&A Session Summary Question: Strength of consumables in the quarter - Management indicated that growth in VetLab consumables is broad-based, driven by a large install base and high-quality placements [33] Question: MU consumables and new contracting terms - The growth in consumables is attributed to the high-quality placements and the introduction of new tests that veterinarians prefer to perform at the point of care [34] Question: MU placements and backlog of customers - Management confirmed that they are on track with MU placements and expect most customers to utilize multiple testing use cases [35] Question: End market visit trends - Management noted that non-wellness visits were closer to flat in Q3, with pressures on wellness visits continuing [38] Question: International CAG diagnostic recurring revenue growth - Management highlighted that international markets are still developing, with significant opportunities for growth as the sales organization matures [49]

#BitgetOnchain Trading Competition 56: Trade $ARIA, $JobIess, $VELO & share 20,000 $BGB!🗓 Sep 18, 11:00 AM – Sep 20 10:59 AM (UTC)✅ Register for the event: https://t.co/cK8nZxfdAk🔹 Top users will win a maximum of 300 BGB!@veloprotocol @PlayAriaGame https://t.co/vYvwFKlYHg ...

#Bitget Onchain Trading Competition 53: Trade $CUDIS, $USDUC, $VELO & share 20,000 $BGB!🗓 Event period: September 15, 11:00 AM – September 18, 10:59 AM (UTC)How to join:✅ Register for the event: https://t.co/XYZxBzG9E6📈 Trade CUDIS, USDUC & VELO on #BitgetOnchain — your volume counts after registration!🔹 Top users by volume will each win a maximum of 200 BGB!@CudisWellness @usduc_coin @veloprotocol ...

Investment Rating - The report maintains an "Outperform" rating for the industry [5] Core Insights - The report highlights the expected acceleration in the new tobacco sector for British American Tobacco in the second half of 2025, driven by strong performance in oral tobacco products and the phased launch of new products [2][6] - The 618 shopping festival is anticipated to boost domestic brands in personal care and outdoor sports, with significant growth potential for companies like Morning Glory and others leveraging IP strategies [2][6] Summary by Sections Home Furnishing - The home furnishing sector is expected to gradually recover as consumer confidence improves, with many companies currently valued at historical lows. Key players to watch include custom furniture leaders like Oppein and Sophia [6][10] Paper and Packaging - As of June 6, 2025, prices for various paper products remain stable, with white cardboard prices increasing slightly. The report suggests a cautious outlook due to overall weak terminal demand [6][54] - The paper industry saw a 1.6% year-on-year decline in revenue from January to April 2025, but fixed asset investment increased by 7.6% during the same period [66][68] Light Industry Consumption - The report notes that domestic brands in personal care are rapidly expanding their market presence, particularly through platforms like Douyin. Companies such as Dekang and Baiya are highlighted for their growth potential [6][8] Export Chain - The report indicates a robust outlook for export-oriented companies, with shipping costs rising due to increased demand for goods from China. Companies like Zhongxin and Zhejiang Nature are recommended for investment [6][8] New Tobacco - British American Tobacco's new tobacco segment is projected to see significant growth in the latter half of 2025, with a full-year growth expectation of mid-single digits, driven by strong performance in oral tobacco and the introduction of new products [6][8] Textile and Apparel - The textile and apparel sector has shown resilience, with notable sales increases during the 618 shopping festival. Brands like Anta and Li Ning are recommended for their strong performance [6][10]